{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T18:30:03Z","timestamp":1648924203685},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Theor Biol Med Model"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1742-4682-11-15","type":"journal-article","created":{"date-parts":[[2014,3,24]],"date-time":"2014-03-24T15:15:02Z","timestamp":1395674102000},"source":"Crossref","is-referenced-by-count":3,"title":["Computing limits on medicine risks based on collections of individual case reports"],"prefix":"10.1186","volume":"11","author":[{"given":"Ola","family":"Caster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G Niklas","family":"Nor\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I Ralph","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,24]]},"reference":[{"issue":"7456","key":"494_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1136\/bmj.329.7456.44","volume":"329","author":"BC Stricker","year":"2004","unstructured":"Stricker BC, Psaty BM:Detection, verification, and quantification of adverse drug reactions. Br Med J. 2004, 329 (7456): 44-47. 10.1136\/bmj.329.7456.44.","journal-title":"Br Med J"},{"issue":"12 II","key":"494_CR2","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.7326\/0003-4819-142-12_Part_2-200506211-00009","volume":"142","author":"R Chou","year":"2005","unstructured":"Chou R, Helfand M:Challenges in systematic reviews that assess treatment harms. Ann Intern Med. 2005, 142 (12 II): 1090-1099.","journal-title":"Ann Intern Med"},{"issue":"6","key":"494_CR3","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/pds.3197","volume":"21","author":"PM Coloma","year":"2012","unstructured":"Coloma PM, Trifir\u00f2 G, Schuemie MJ, Gini R, Herings R, Hippisley-Cox J, Mazzaglia G, Picelli G, Corrao G, Pedersen L, van der Lei J, Sturkenboom M:Electronic healthcare databases for active drug safety surveillance: Is there enough leverage?. Pharmacoepidemiol Drug Saf. 2012, 21 (6): 611-621. 10.1002\/pds.3197.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"494_CR4","unstructured":"Caster O:Quantitative methods to support drug benefit-risk assessment. PhD thesis. Stockholm University, Department of Computer and Systems Sciences; 2014,"},{"key":"494_CR5","volume-title":"Practical Aspects of Signal Detection in Pharmacovigilance","author":"CIOMS Working Group XIII","year":"2010","unstructured":"CIOMS Working Group XIII: Practical Aspects of Signal Detection in Pharmacovigilance. 2010, Geneva, Switzerland: CIOMS"},{"issue":"6","key":"494_CR6","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/j.1365-2125.2011.04087.x","volume":"72","author":"A De Boer","year":"2011","unstructured":"De Boer A:When to publish measures of disproportionality derived from spontaneous reporting databases?. Br J Clin Pharmacol. 2011, 72 (6): 909-911. 10.1111\/j.1365-2125.2011.04087.x.","journal-title":"Br J Clin Pharmacol"},{"key":"494_CR7","volume-title":"ICH harmonised tripartite guideline: Periodic Benefit-Risk Evaluation Report (PBRER)","author":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH)","year":"2012","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH):ICH harmonised tripartite guideline: Periodic Benefit-Risk Evaluation Report (PBRER). 2012 http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E2C\/E2C_R2_Step4.pdf"},{"issue":"5","key":"494_CR8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1524-4733.2010.00725.x","volume":"13","author":"JJ Guo","year":"2010","unstructured":"Guo JJ, Pandey S, Doyle J, Bian B, Lis Y, Raisch DW:A review of quantitative risk-benefit methodologies for assessing drug safety and efficacy - Report of the ISPOR risk-benefit management working group. Value Health. 2010, 13 (5): 657-666. 10.1111\/j.1524-4733.2010.00725.x.","journal-title":"Value Health"},{"issue":"9","key":"494_CR9","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/pds.3464","volume":"22","author":"J Leong","year":"2013","unstructured":"Leong J, Mcauslane N, Walker S, Salek S:Is there a need for a universal benefit-risk assessment framework for medicines? Regulatory and industry perspectives. Pharmacoepidemiol Drug Saf. 2013, 22 (9): 1004-1012.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"494_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2125.1988.tb03356.x","volume":"26","author":"MD Rawlins","year":"1988","unstructured":"Rawlins MD:Spontaneous reporting of adverse drug reactions I: the data. Br J Clin Pharmacol. 1988, 26 (1): 1-5. 10.1111\/j.1365-2125.1988.tb03356.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"494_CR11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/009286150804200501","volume":"42","author":"M Lindquist","year":"2008","unstructured":"Lindquist M:VigiBase, the WHO global ICSR database system: basic facts. Drug Inform J. 2008, 42 (5): 409-419.","journal-title":"Drug Inform J"},{"issue":"3","key":"494_CR12","doi-asserted-by":"publisher","first-page":"e33536","DOI":"10.1371\/journal.pone.0033536","volume":"7","author":"H Nohynek","year":"2012","unstructured":"Nohynek H, Jokinen J, Partinen M, Vaarala O, Kirjavainen T, Sundman J, Himanen S-L, Hublin C, Julkunen I, Ols\u00e9n P, Saarenp\u00e4\u00e4-Heikkil\u00e4 O, Kilpi T:AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS ONE. 2012, 7 (3): e33536-10.1371\/journal.pone.0033536.","journal-title":"PLoS ONE"},{"issue":"7897","key":"494_CR13","first-page":"f794","volume":"346","author":"E Miller","year":"2013","unstructured":"Miller E, Andrews N, Stellitano L, Stowe J, Winstone AM, Shneerson J, Verity C:Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A\/H1N1 2009 influenza vaccine: Retrospective analysis. BMJ (Online). 2013, 346 (7897): f794-","journal-title":"BMJ (Online)"},{"issue":"2","key":"494_CR14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/joim.12150","volume":"275","author":"I Persson","year":"2014","unstructured":"Persson I, Granath F, Askling J, Ludvigsson JF, Olsson T, Feltelius N:Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with pandemrix: A population- and registry-based cohort study with over 2 years of follow-up. J Int Med. 2014, 275 (2): 172-190. 10.1111\/joim.12150.","journal-title":"J Int Med"},{"key":"494_CR15","doi-asserted-by":"publisher","first-page":"216ra176","DOI":"10.1126\/scitranslmed.3007762","volume":"5","author":"AK De La Herr\u00e1n-Arita","year":"2013","unstructured":"De La Herr\u00e1n-Arita AK, Kornum BR, Mahlios J, Jiang W, Lin G, Hou T, Macaubas C, Einen M, Plazzi G, Crowe C, Newell EW, Davis MM, Mellins ED, Mignot E:CD4+ T cell autoimmunity to hypocretin\/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy. Sci Trans Med. 2013, 5: 216ra176-10.1126\/scitranslmed.3007762.","journal-title":"Sci Trans Med"},{"issue":"5","key":"494_CR16","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S1473-3099(13)70117-8","volume":"13","author":"K Morris","year":"2013","unstructured":"Morris K:Implications of narcolepsy link with swine-influenza vaccine. Lancet Infect Dis. 2013, 13 (5): 396-397. 10.1016\/S1473-3099(13)70117-8.","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"494_CR17","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/pds.3478","volume":"22","author":"S Toh","year":"2013","unstructured":"Toh S, Avorn J, D\u2019Agostino RB, Gurwitz JH, Psaty BM, Rothman KJ, Saag KG, Sturkenboom MCJM, Vandenbroucke JP, Winterstein AG, Strom BL:Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs. Pharmacoepidemiol Drug Saf. 2013, 22 (10): 1036-1045.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"494_CR18","volume-title":"Modular program report: Angiotensin Receptor Blockers (ARBs), hydrochlorothiazide, atenolol, amlodipine use & celiac disease","author":"Mini-Sentinel","year":"2013","unstructured":"Mini-Sentinel:Modular program report: Angiotensin Receptor Blockers (ARBs), hydrochlorothiazide, atenolol, amlodipine use & celiac disease. 2013, [ http:\/\/www.mini-sentinel.org\/work_products\/Assessments\/Mini-Sentinel_Modular-Program-Report_MSY3_MPR34_ARBs-HCTZ-Atenolol-Amlodipine-Celiac-Disease.pdf ], []"},{"key":"494_CR19","volume-title":"Distributed Database Summary Report - Year 3","author":"Mini-Sentinel","year":"2014","unstructured":"Mini-Sentinel:Distributed Database Summary Report - Year 3. 2014, http:\/\/www.mini.sentinel.org\/work_products\/Data_Activities\/Mini-Sentinel_Year-3-Distributed-Database-Summary-Report.pdf ,"},{"issue":"3","key":"494_CR20","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10618-006-0052-8","volume":"14","author":"GN Nor\u00e9n","year":"2007","unstructured":"Nor\u00e9n GN, Orre R, Bate A, Edwards IR:Duplicate detection in adverse drug reaction surveillance. Data Min Knowl Discov. 2007, 14 (3): 305-328. 10.1007\/s10618-006-0052-8.","journal-title":"Data Min Knowl Discov"},{"issue":"5","key":"494_CR21","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","volume":"29","author":"L Hazell","year":"2006","unstructured":"Hazell L, Shakir SAW:Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006, 29 (5): 385-396. 10.2165\/00002018-200629050-00003.","journal-title":"Drug Saf"},{"issue":"1","key":"494_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2165\/00002018-200932010-00002","volume":"32","author":"E Lopez-Gonzalez","year":"2009","unstructured":"Lopez-Gonzalez E, Herdeiro MT, Figueiras A:Determinants of under-reporting of adverse drug reactions: A systematic review. Drug Saf. 2009, 32 (1): 19-31. 10.2165\/00002018-200932010-00002.","journal-title":"Drug Saf"},{"issue":"1","key":"494_CR23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3233\/JRS-2012-0552","volume":"24","author":"IR Edwards","year":"2012","unstructured":"Edwards IR:Considerations on causality in pharmacovigilance. Int J Risk Saf Med. 2012, 24 (1): 41-54.","journal-title":"Int J Risk Saf Med"},{"issue":"6","key":"494_CR24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2165\/00002018-200022060-00001","volume":"22","author":"RH Meyboom","year":"2000","unstructured":"Meyboom RH, Lindquist M, Egberts AC:An ABC of drug-related problems. Drug Saf. 2000, 22 (6): 415-423. 10.2165\/00002018-200022060-00001.","journal-title":"Drug Saf"},{"issue":"12","key":"494_CR25","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/sim.4194","volume":"30","author":"T Tervonen","year":"2011","unstructured":"Tervonen T, van Valkenhoef G, Buskens E, Hillege HL, Postmus D:A stochastic multicriteria model for evidence-based decision making in drug benefit-risk analysis. Stat Med. 2011, 30 (12): 1419-1428. 10.1002\/sim.4194.","journal-title":"Stat Med"},{"issue":"6","key":"494_CR26","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1177\/0272989X12451338","volume":"32","author":"O Caster","year":"2012","unstructured":"Caster O, Nor\u00e9n GN, Ekenberg L, Edwards IR:Quantitative benefit-risk assessment using only qualitative information on utilities. Med Decis Mak. 2012, 32 (6): E1-E15. 10.1177\/0272989X12451338.","journal-title":"Med Decis Mak"},{"issue":"SUPPL. 1","key":"494_CR27","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1002\/pds.1435","volume":"16","author":"F Mussen","year":"2007","unstructured":"Mussen F, Salek S, Walker S:A quantitative approach to benefit-risk assessment of medicines - part 1 The development of a new model using multi-criteria decision analysis. Pharmacoepidemiol Drug Saf. 2007, 16 (SUPPL. 1): S2-S15.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6135","key":"494_CR28","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/bmj.2.6135.464","volume":"2","author":"U Bergman","year":"1978","unstructured":"Bergman U, Boman G, Wiholm BE:Epidemiology of adverse drug reactions to phenformin and metformin. Br Med J. 1978, 2 (6135): 464-466. 10.1136\/bmj.2.6135.464.","journal-title":"Br Med J"},{"issue":"2","key":"494_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1742-7843.2009.00494.x","volume":"106","author":"K Furu","year":"2010","unstructured":"Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, S\u00f8rensen HT:The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol. 2010, 106 (2): 86-94. 10.1111\/j.1742-7843.2009.00494.x.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"9084","key":"494_CR30","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/S0140-6736(97)04248-7","volume":"350","author":"T Walley","year":"1997","unstructured":"Walley T, Mantgani A:The UK general practice research database. Lancet. 1997, 350 (9084): 1097-1099. 10.1016\/S0140-6736(97)04248-7.","journal-title":"Lancet"}],"container-title":["Theoretical Biology and Medical Modelling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4682-11-15.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T18:55:44Z","timestamp":1597604144000},"score":1,"resource":{"primary":{"URL":"https:\/\/tbiomed.biomedcentral.com\/articles\/10.1186\/1742-4682-11-15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,24]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["494"],"URL":"https:\/\/doi.org\/10.1186\/1742-4682-11-15","relation":{},"ISSN":["1742-4682"],"issn-type":[{"value":"1742-4682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,24]]},"article-number":"15"}}